Literature DB >> 25584312

Detection of rankl positive cells in gingival tissue in healthy & chronic periodontal disease patients-a comparative study.

J Bhuvaneswarri1, Bagavad Gita2, S C Chandrasekaran3.   

Abstract

UNLABELLED: Aim & Objective: The receptor activator of NF-kappa B ligand (RANKL) and its decoy receptor, osteoprotegerin (OPG), are the important proteins implicated in osteoclastogenesis. This study aimed to identify & quantify RANKL positive cells in gingival tissues in healthy & diseased patients & the study looks for immunohistochemical evidence of the expression of the protein in gingival tissue samples.
MATERIALS AND METHODS: Patients were randomly selected. Thirty subject each for (test & control). Age range of 25-55y, either sex was selected. Tissue samples were collected from Control - Healthy Gingiva & Test-Chronic Periodontitis Patients. Tissue sections were prepared. An Immunohistochemical analysis was done & cell counting was done for RANKL positive cells.
RESULTS: Immunohistochemical staining showed that RANKL-positive cells were significantly distributed in the inflammatory epithelium &amp; connective tissue zone of diseased &amp; non-diseased gingiva. RANKL, positive cells was increased significantly in patients with chronic periodontitis (p < 0.05).
CONCLUSION: These findings imply that in this comparative study of gingival tissue for, RANKL positive cells, these cells were present in both healthy &amp; chronic periodontitis samples, but number of positive cells present is significantly increased in chronic periodontitis.

Entities:  

Keywords:  Chronic periodontitis; Osteoprotegrin; RANKL

Year:  2014        PMID: 25584312      PMCID: PMC4290317          DOI: 10.7860/JCDR/2014/9876.5125

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  17 in total

Review 1.  Novel host response therapeutic approaches to treat periodontal diseases.

Authors:  Keith L Kirkwood; Joni A Cirelli; Jill E Rogers; William V Giannobile
Journal:  Periodontol 2000       Date:  2007       Impact factor: 7.589

Review 2.  Roles of receptor activator of nuclear factor-kappaB ligand (RANKL) and osteoprotegerin in periodontal health and disease.

Authors:  Toshiyuki Nagasawa; Makoto Kiji; Reiko Yashiro; Doosadee Hormdee; He Lu; Melanie Kunze; Tomonari Suda; Geena Koshy; Hiroaki Kobayashi; Shigeru Oda; Hiroshi Nitta; Isao Ishikawa
Journal:  Periodontol 2000       Date:  2007       Impact factor: 7.589

3.  Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.

Authors:  W S Simonet; D L Lacey; C R Dunstan; M Kelley; M S Chang; R Lüthy; H Q Nguyen; S Wooden; L Bennett; T Boone; G Shimamoto; M DeRose; R Elliott; A Colombero; H L Tan; G Trail; J Sullivan; E Davy; N Bucay; L Renshaw-Gegg; T M Hughes; D Hill; W Pattison; P Campbell; S Sander; G Van; J Tarpley; P Derby; R Lee; W J Boyle
Journal:  Cell       Date:  1997-04-18       Impact factor: 41.582

4.  Identification of the osteoprotegerin/receptor activator of nuclear factor-kappa B ligand system in gingival crevicular fluid and tissue of patients with chronic periodontitis.

Authors:  H-K Lu; Y-L Chen; H-C Chang; C-L Li; M Y-P Kuo
Journal:  J Periodontal Res       Date:  2006-08       Impact factor: 4.419

5.  Levels of cytokine receptor activator of nuclear factor kappaB ligand in gingival crevicular fluid in untreated chronic periodontitis patients.

Authors:  Rolando Vernal; Alejandra Chaparro; Rebecca Graumann; Javier Puente; Maria Antonieta Valenzuela; Jorge Gamonal
Journal:  J Periodontol       Date:  2004-12       Impact factor: 6.993

6.  Porphyromonas gingivalis antigen preferentially stimulates T cells to express IL-17 but not receptor activator of NF-kappaB ligand in vitro.

Authors:  T Oda; H Yoshie; K Yamazaki
Journal:  Oral Microbiol Immunol       Date:  2003-02

Review 7.  Clinical applications of RANK-ligand inhibition.

Authors:  E Romas
Journal:  Intern Med J       Date:  2009-02       Impact factor: 2.048

Review 8.  RANKL/RANK/OPG: key therapeutic target in bone oncology.

Authors:  Kosei Ando; Kanji Mori; Francoise Rédini; Dominique Heymann
Journal:  Curr Drug Discov Technol       Date:  2008-09

9.  Expression and role of RANKL in periodontal ligament cells during physiological root-resorption in human deciduous teeth.

Authors:  Hidefumi Fukushima; Hiroshi Kajiya; Keisuke Takada; Fujio Okamoto; Koji Okabe
Journal:  Eur J Oral Sci       Date:  2003-08       Impact factor: 2.612

10.  Problems and proposals for recording gingivitis and plaque.

Authors:  J Ainamo; I Bay
Journal:  Int Dent J       Date:  1975-12       Impact factor: 2.512

View more
  3 in total

1.  RANK/RANKL/OPG Signalization Implication in Periodontitis: New Evidence from a RANK Transgenic Mouse Model.

Authors:  Bouchra Sojod; Danielle Chateau; Christopher G Mueller; Sylvie Babajko; Ariane Berdal; Frédéric Lézot; Beatriz Castaneda
Journal:  Front Physiol       Date:  2017-05-24       Impact factor: 4.566

Review 2.  Pharmacological Therapies for the Management of Inflammatory Bone Resorption in Periodontal Disease: A Review of Preclinical Studies.

Authors:  Angelica Leticia Reis Pavanelli; Bruna Silva de Menezes; Erica Bianca Barbosa Pereira; Fabio Assuncao de Souza Morais; Joni Augusto Cirelli; Rafael Scaf de Molon
Journal:  Biomed Res Int       Date:  2022-05-02       Impact factor: 3.246

Review 3.  Relationship between Periodontitis and Rheumatoid Arthritis: Review of the Literature.

Authors:  Vilana Maria Adriano Araújo; Iracema Matos Melo; Vilma Lima
Journal:  Mediators Inflamm       Date:  2015-08-04       Impact factor: 4.711

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.